Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 37 out of 100. Inflammation and the immune system

Topic: Brain proteins, microglia and lab models

Plain-language summary

In particular, the severity of HIV-associated neurocognitive disorders (HAND) has been greatly reduced, significantly decreasing the prevalence of HIV-associated dementia [1]. However, the overall prevalence of milder forms of HAND remains comparable to the pre-ART era [2; 3; 4].Neurocognitive impairment affects nearly 50% of people living with HIV (PLWH), yet the HIVspecific factors responsible for this co-morbidity remain poorly understood. This model is consistent with ART-suppressed HIV infection in people, as EcoHIV establishes latent infection of the murine brain [12].Considering brain inflammation, expression of inflammatory cytokines in mice infected with Nefdeficient EcoHIV was between the levels observed in mock-infected mice and mice infected with Nef-positive EcoHIV, and significantly differed from both [10], indicating that other HIV factors besides Nef contributed to neuroinflammation. Interestingly, the effects of Nef and the other HIV factors (presumably Tat) on neuroinflammation appear additive, suggesting that they may work throw different mechanisms. These findings also argue against the direct acute cytotoxicity of Tat proposed in previous studies [16]. Notably, Tat concentrations in the cerebrospinal fluid (CSF) of ART-treated PLWH range from 0.5 to 6.5 ng/mL (36-465 pM) [18], which is significantly lower than the neurotoxic concentrations used in in vitro studies. Collectively, these results suggest that Nef is a primary driver of acute neuroinflammation, myelin impairment and neuronal damage in the EcoHIV model of HAND. This mechanism is particularly significant because it offers a novel explanation for how Nef may propagate neurotoxic effects throughout the brain without requiring direct viral infection of every affected cell. Importantly, even when HIV replication is suppressed to undetectable levels by ART, Nef EVs continue to be produced [26] and remain capable of exerting neurotoxic effects.This study demonstrated that Nef-containing EVs disrupted myelin sheaths and inflicted damage upon glial cells, in particular oligodendrocytes, within the murine CNS. The damage to oligodendrocytes was partially prevented by agents that blocked Nef-mediated inhibition of the activity of cellular cholesterol transporter, ABCA1, suggesting that the effects of Nef EVs on myelination were mediated by alterations in cholesterol homeostasis, a known feature of Nef EVs [15]. In addition, Nef EVs promoted inflammatory responses by significantly incre

What this study adds

Evidence grade: Low

In a mouse model of HIV infection, the viral protein Nef contributed to neuroinflammation and myelin impairment, with effects appearing additive to other HIV factors. This is animal and laboratory research on HIV-related cognitive problems, not a treatment or prevention for Alzheimer's disease.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Bukrinsky, M. (2025). Nef is a key player in neuroinflammation and myelin impairment associated with neuroHIV. Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1553594

Vancouver

Bukrinsky M. Nef is a key player in neuroinflammation and myelin impairment associated with neuroHIV. Frontiers in Neurology. 2025. doi:10.3389/fneur.2025.1553594. PMID: 40144622.

BibTeX

@article{bukrinsky2025-40144622,
  author  = {Bukrinsky, Michael},
  title   = {{Nef is a key player in neuroinflammation and myelin impairment associated with neuroHIV}},
  journal = {Frontiers in Neurology},
  year    = {2025},
  doi     = {10.3389/fneur.2025.1553594},
  pmid    = {40144622},
  url     = {https://doi.org/10.3389/fneur.2025.1553594}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

Key findings

Why it matters

In a mouse model of HIV infection, the viral protein Nef contributed to neuroinflammation and myelin impairment, with effects appearing additive to other HIV factors. This is animal and laboratory research on HIV-related cognitive problems, not a treatment or prevention for Alzheimer's disease.

Study details

How this study scored 37/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 0 of 4; Effect reported 0 of 3; Studied in people 0 of 3; Randomized / blinded 0 of 2; Times cited 1 of 7; Citations per year 1 of 5; Impact for its field and year 2 of 6; Cited by studies here 0 of 6; Still being cited 1 of 4; Senior author's track record 3 of 4; Institution's track record 1 of 3; Multicenter collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 37 of 100.37 of 100 points earned63 not earned

Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Frontiers in Neurology)
Journal's citation record 2 / 4 Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 0 / 4 Participant count not stated — scores zero (not stated in the record — scored 0)
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 0 / 3 Not stated whether this was studied in people — scores zero (not stated in the record — scored 0)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 1 / 7 Cited 4 times (OpenAlex, 2026-10-10)
Citations per year 1 / 5 1.3 citations a year over 3 year(s) since 2025
Impact for its field and year 2 / 6 Cited 1.8× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 1 / 4 Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 3 / 4 Last-listed author Michael Bukrinsky: h-index 58 (OpenAlex, whole career)
Institution's track record 1 / 3 George Washington University: institution h-index 881 (OpenAlex)
Multicenter collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 40144622)
Free to read 2 / 2 Free to read
Total 37 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Inflammation and the immune system from nearby years

Also tagged “small”

900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Inflammation and the immune system

See all studies in Inflammation and the immune system →